Taiho Oncology, Inc. | Making the Human Connection

Features

Product Pipeline

Find out about the anti-cancer drugs we have in development

TAIHO ONCOLOGY, INC.

Learn more about our company history and overall mission

CULTURE

Hear first-hand what it is like to work at Taiho Oncology

Press Releases

Taiho Oncology Announces Presentation of Phase 2 Data for Futibatinib (TAS-120) in Advanced Intrahepatic Cholangiocarcinoma at Virtual AACR Annual Meeting 2021
Taiho Oncology To Present Phase 2 Data for Futibatinib (TAS-120) in Advanced Intrahepatic Cholangiocarcinoma at Virtual AACR Annual Meeting 2021
FDA Grants Breakthrough Therapy Designation for Taiho Oncology’s Futibatinib for Treatment of Advanced Cholangiocarcinoma

See how Taiho is making a difference in our community!

Our Initiatives

Job Postings

Considering a career at Taiho Oncology? Search our Job Board!